Specialty Pharmaceutical Hubs or Reimbursement Hubs, also known as integrated service providers, operate somewhat behind the scenes, offering a range of activities for payers, patients, and providers related to reimbursement and patient access support services.
Hubs facilitate communication among all parties in the specialty prescription process, offering strategic market advantages to pharma and biotech manufacturers.
A 3D printer uses data from individual patients to replicate hearts of children, reflecting their particular intricacies and deformities at Children’s National Medical Center.
Nearly all Kaiser Permanente hospitals have once again received an A grade for patient safety — and none lower than a B — in The Leapfrog Group’s latest Hospital Safety Score report.
U.S. hospitals are absorbing an estimated $8.3 billion annual hit in lost productivity and increased patient discharge times by not using the latest mobile devices and Internet services to deliver patient care, according to a Ponemon Institute survey.
Eli Lilly’s massive restructuring of its sales force will affect more employees than the Indianapolis-based drugmaker disclosed in early April. Lilly will eliminate 1,624 positions from its U.S. sales force in July.
AbbVie said that its new hepatitis C drug regimen has been given a breakthrough therapy designation by the Food and Drug Administration, putting it on the fast track for potential approval in the United States.
The AP reports that companies are developing “miniature medical devices that tap the power of the ubiquitous smartphone in hopes of changing how people monitor their own health.
Bloomberg reported Merck has been eliminating thousands of jobs and trying to boost demand of existing products to overcome the revenue drop from its once-leading drug Singulair, an asthma medication that began facing competition from cheaper copies in August.
Walgreens’ Take Care clinics, which are retail clinics that treat patients for conditions like sore throats and minor injuries, will expand to offer customers help in managing chronic diseases like asthma and diabetes.
The city of Chicago is the latest to join the biotech trend. Chicago Mayor Rahm Emanuel yesterday disclosed plans for a downtown biopharma center designed to assist startups and house companies.
- Page 1 of 88
- Next »
